1 INTRODUCTION {#SEC1}
==============

Alternative splicing of precursor mRNAs is a prevalent regulatory mechanism in higher eukaryotes. Recent data suggest that over 90% of multi-exon human genes are alternatively spliced (Blencowe *et al.*, [@B1]). Use of splicing-sensitive microarrays is a popular approach for global profiling of alternative splicing events. One widely used commercial platform is the Affymetrix exon 1.0 array (Clark *et al.*, [@B2]). This array allocates on average four probes per exon for all transcript-confirmed and predicted exons in a mammalian genome, allowing for concurrent profiling of gene expression levels and alternative splicing events. Since its release, a variety of algorithms for splicing analysis using the exon 1.0 array have been proposed \[for a summary of these algorithms, see (Laajala *et al.*, [@B4])\].

However, as a first-generation exon array platform, the design of the Affymetrix exon 1.0 array has its limitations. Most importantly, the array has only four probes per exon and no probes targeting exon--exon junctions. To address these limitations, Affymetrix recently released its second-generation exon array, the Human Exon Junction Array (HJAY), with a significantly improved probe design. This new array averages eight probes per probeset for 315 137 exons and 260 488 exon--exon junctions in the human genome, covering all alternative splicing events with mRNA/EST evidence in the UCSC/Ensembl databases (Yamamoto *et al.*, [@B9]). The increased probe density, inclusion of exon--exon junction probes and comprehensive coverage of known alternative splicing events make the HJAY a powerful platform for analysis of alternative splicing. Building on our previous work on the exon 1.0 array (Xing *et al.*, [@B8]), we have developed a pipeline, MADS+, for splicing analysis using the new Affymetrix exon junction array.

2 DESCRIPTIONS {#SEC2}
==============

MADS+ is implemented in Python/R and can be run on any Linux/Unix-like environment with installation of Python, R and required packages. An overview of the MADS+ pipeline is provided below:

*Preprocessing*: raw junction array CEL files are processed by the ProbeEffects program (Kapur *et al.*, [@B3]). A variety of background-correction and normalization methods are implemented in ProbeEffects. In particular, we employ a linear model with 80 parameters to correct for the background intensities of individual probes based on nucleotides at each position of a 25mer probe (Kapur *et al.*, [@B3]). The background-corrected intensities are used for downstream analysis.

*Expression Index Calculation*: for each gene, the background corrected and normalized intensities of its exon probes are used to derive an index for overall gene expression levels. The ProbeSelect program implements an iterative probe selection algorithm to select a subset of exon probes for each gene with highly correlated intensities across all samples (Xing *et al.*, [@B7]). These probes are treated as reliable indicators of overall gene expression levels and their probe intensities are fitted to the Li-Wong model to calculate expression indexes (Li *et al.*, [@B5]; Xing *et al.*, [@B7]).

*Alternative Splicing Analysis*: the alternative splicing analysis in MADS+ consists of several steps. First, for each probe in a particular sample, we calculate a 'splicing index', represented as the background corrected probe intensity divided by the estimated gene expression index. Two separate one-sided *t*-tests are performed to test if the splicing index of a probe is substantially higher in one sample group over the other group. Then, for each probeset, the *P*-values of individual probes are summarized using Fisher\'s method to obtain a probeset-level *P*-value for differential splicing (Xing *et al.*, [@B8]). Next, MADS+ reads precompiled annotation files of alternative splicing events queried by the exon junction array. For each alternative splicing event, MADS+ evaluates the *P*-values of multiple probesets targeting exons and exon--exon junctions, requiring opposite trends for probesets targeting competing isoforms as evidence of differential splicing. For example, for each exon skipping event, we require that the 'skip' probeset and at least one of the three 'include' probesets (see [Fig. 1](#F1){ref-type="fig"}A) have *P*-values below a predefined significance cutoff (default is 0.001), and that significant 'include' and 'skip' probesets display opposite directions of change in splicing index between the two sample groups. Finally, for candidate differential splicing events, MADS+ plots the background-corrected intensities of individual probes as well as the estimated gene expression indexes, allowing users to directly inspect the evidence for splicing differences between sample groups (see [Fig. 1](#F1){ref-type="fig"}C for an example). It also produces annotated text output grouped according to the types of alternative splicing patterns (e.g. exon skipping, alternative splice site usage, mutually exclusive exon usage). This facilitates downstream analysis of identified differential splicing events. Fig. 1.Detection of a differentially spliced cassette exon using MADS+. (**A**) The HJAY probe design for cassette exons. Each probeset has eight probes. (**B**) Exon 13 of *SLK* is positively regulated by ESRP1. (**C**) The HJAY data indicate significantly elevated exon inclusion of *SLK* exon 13 in response to ESRP1 overexpression. In each panel, the dashed red line indicates the average gene expression levels of *SLK* in four replicate samples transduced with EV or ESRP1. The individual blue lines indicate the average background-corrected intensities of individual probes in a probeset. MADS+ *P*-value is shown below the name of each probeset. The '+' and '−' signs indicate the direction of change in splicing indexes from EV to ESRP1.

3 EXAMPLES {#SEC3}
==========

The MADS+ pipeline has been used routinely in our exon-level analysis of the Affymetrix HJAY data. [Figure 1](#F1){ref-type="fig"} shows a candidate differential exon skipping event identified by MADS+. In this study, in order to identify splicing events regulated by the novel epithelial-specific splicing regulator ESRP1 (Warzecha *et al.*, [@B6]), a cDNA for mouse ESRP1 was ectopically expressed in the MDA-MB-231 mesenchymal human breast cancer cell line by viral transduction compared with empty vector (EV) control and profiled by the Affymetrix HJAY (four biological replicates each condition). As shown in [Figure 1](#F1){ref-type="fig"}, exon 13 of the *SLK* gene was positively regulated by ESRP1. Its exon inclusion level was 2% after transduction by EV and 80% after transduction by ESRP1. From the HJAY data of this exon, we found significantly elevated splicing indexes of the exon inclusion probesets (upstream junction, downstream junction and exon) and significantly reduced splicing indexes of the exon skipping probeset in the ESRP1 group as compared with the EV group ([Fig. 1](#F1){ref-type="fig"}C), which was validated by RT-PCR ([Fig. 1](#F1){ref-type="fig"}B). In sum, among ESRP1-dependent exon skipping events identified by MADS+, we obtained a RT-PCR validation rate of 88.5% (153 exons validated out of 173 tested so far, Warzecha,C.C. *et al.*, unpublished data). This example demonstrates that MADS+ is a useful tool for global analysis and visualization of differential alternative splicing.
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